Literature DB >> 20021293

Voriconazole therapeutic drug monitoring: focus on safety.

Alessandro C Pasqualotto1, Melissa O Xavier, Huander F Andreolla, Rafael Linden.   

Abstract

IMPORTANCE OF THE FIELD: Voriconazole has been widely used for the treatment of invasive fungal diseases, particularly invasive aspergillosis. Drug-drug interactions are, however, the main drawback associated with voriconazole use, since this drug suffers from extensive hepatic metabolism. AREAS COVERED IN THIS REVIEW: This article reviews the current literature on voriconazole therapeutic drug monitoring, with a special focus on drug safety. WHAT THE READER WILL GAIN: An update on voriconazole metabolism, drug interactions, toxicity and the relation of these with voriconazole drug concentrations. TAKE HOME MESSAGE: Therapy with voriconazole may be better guided by measuring voriconazole concentrations in the plasma.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20021293     DOI: 10.1517/14740330903485637

Source DB:  PubMed          Journal:  Expert Opin Drug Saf        ISSN: 1474-0338            Impact factor:   4.250


  22 in total

1.  Clinical importance of the CYP2C19*17 variant allele for voriconazole.

Authors:  Michael J Dolton; Andrew J McLachlan
Journal:  Br J Clin Pharmacol       Date:  2011-01       Impact factor: 4.335

2.  [Not Available].

Authors:  Jf Arnould; R Le Floch
Journal:  Ann Burns Fire Disasters       Date:  2015-03-31

3.  Role of Aspergillus lentulus 14-α sterol demethylase (Cyp51A) in azole drug susceptibility.

Authors:  Emilia Mellado; Laura Alcazar-Fuoli; Manuel Cuenca-Estrella; Juan L Rodriguez-Tudela
Journal:  Antimicrob Agents Chemother       Date:  2011-09-26       Impact factor: 5.191

Review 4.  [Candida infections in the elderly].

Authors:  H Hof; G Mikus
Journal:  Z Gerontol Geriatr       Date:  2013-01       Impact factor: 1.281

5.  Observational Study of Associations between Voriconazole Therapeutic Drug Monitoring, Toxicity, and Outcome in Liver Transplant Patients.

Authors:  Zahra Hashemizadeh; Parisa Badiee; Seyed Ali Malekhoseini; Hadi Raeisi Shahraki; Bita Geramizadeh; Hashem Montaseri
Journal:  Antimicrob Agents Chemother       Date:  2017-11-22       Impact factor: 5.191

6.  Correlation of CYP2C19 genotype with plasma voriconazole levels: a preliminary retrospective study in Indians.

Authors:  Prerna K Chawla; Shweta R Nanday; Alpa J Dherai; Rajeev Soman; Rohan V Lokhande; Prasad R Naik; Tester F Ashavaid
Journal:  Int J Clin Pharm       Date:  2015-05-30

7.  Therapeutic drug monitoring in voriconazole-associated hyponatremia.

Authors:  Ren-Ai Xu; Shuang-Li Zheng; Li-Li Xiao; Xue-Ding Cai; Xi-Xi Lai; Guan-Yang Lin; Lu-Feng Hu; Chun-Hong Zhang; Zhi-Sheng Xu; Xiu-Hua Zhang
Journal:  Med Mycol Case Rep       Date:  2013-06-19

8.  Plasma Voriconazole Estimation by HPLC.

Authors:  Prerna K Chawla; Alpa J Dherai; Tester F Ashavaid
Journal:  Indian J Clin Biochem       Date:  2015-05-01

9.  Longitudinal Analysis of the Effect of Inflammation on Voriconazole Trough Concentrations.

Authors:  M A Encalada Ventura; M J P van Wanrooy; L F R Span; M G G Rodgers; E R van den Heuvel; D R A Uges; T S van der Werf; J G W Kosterink; J W C Alffenaar
Journal:  Antimicrob Agents Chemother       Date:  2016-04-22       Impact factor: 5.191

10.  Highly variable plasma concentrations of voriconazole in pediatric hematopoietic stem cell transplantation patients.

Authors:  Imke H Bartelink; Tom Wolfs; Martine Jonker; Marjolein de Waal; Toine C G Egberts; Tessa T Ververs; Jaap J Boelens; Marc Bierings
Journal:  Antimicrob Agents Chemother       Date:  2012-10-31       Impact factor: 5.191

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.